Status:
COMPLETED
Effect of Transcutaneous Electrical Nerve Stimulation on CIPN Symptoms
Lead Sponsor:
Jordan University of Science and Technology
Collaborating Sponsors:
King hussein cancer foundation and center
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and debilitating survivorship conditions for patients with cancer, and one of the most common side effects of ch...
Detailed Description
Chemotherapy Induced Peripheral Neuropathy (CIPN) is a common and serious side effect of chemotherapy treatment that causes autonomic neurons, sensory, or motor nerve damage or dysfunction. CIPN devel...
Eligibility Criteria
Inclusion
- patients will be invited if they ≥18 years
- were not previously received any session of TENS device
- on gabapentin drug currently
Exclusion
- skin conditions (lesions or open sores)
- cognitive difficulties or trouble understanding
- history of peripheral neuropathy due to receiving neurotoxic chemotherapy
- cardiac pacemakers
- have ever used TENS device treatment
- chronic conditions (diabetes mellitus, brain damage, history of epilepsy, or taking anticonvulsants drugs)
- pregnant women
Key Trial Info
Start Date :
August 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06499103
Start Date
August 8 2023
End Date
June 29 2024
Last Update
July 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jordan university of science and technology
Irbid, Jordan, 21540